Caregiver‐reported symptom burden and preferences for therapeutic goals in pediatric primary sclerosing cholangitis
- 20 June 2024
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 79 (4) , 835-840
Abstract
This study analyzed qualitative and quantitative survey responses from 51 pediatric primary sclerosing cholangitis (PSC) patients and caregivers using the PSC Partners Patient Registry–Our Voices survey. The most common symptoms reported by children/caregivers include: fatigue (71%), abdominal pain (69%), anxiety (59%), appetite loss (51%), insomnia (49%), and pruritus (45%). When experiencing symptoms at their worst, over half of patients/caregivers reported limitations in physically demanding activities (67%), work/school duties (63%), social life activities (55%), and activities for fun or exercise (53%). Over half of patients/caregivers expressed willingness to participate in clinical trials, however none reported ever participating in trials for new or investigational PSC drugs. This study revealed a substantial patient/caregiver‐reported symptom burden for children with PSC that impacts quality of life and limits access to clinical trials. Future efforts should focus on developing patient‐centered clinical endpoints for PSC trials, increasing trial availability for pediatric PSC patients, and reducing logistical barriers to trial involvement.Keywords
This publication has 17 references indexed in Scilit:
- Recent Insights into Pediatric Primary Sclerosing CholangitisClinics in Liver Disease, 2022
- Pediatric Autoimmune Liver DiseasesPediatric Clinics of North America, 2021
- Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online RegistryClinical Gastroenterology and Hepatology, 2019
- Endpoints in the design of clinical trials for primary sclerosing cholangitisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Primary sclerosing cholangitis: A review and updateLiver Research, 2017
- Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing CholangitisGastroenterology, 2017
- Primary Sclerosing CholangitisNew England Journal of Medicine, 2016
- Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitisHepatology, 2013
- Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden†Hepatology, 2010
- Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic reviewCancer, 2007